​

Lyell Immunopharma (LYEL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Lyell Immunopharma Revenue Highlights

Latest Revenue (Y)

$36.00K

Latest Revenue (Q)

$4.00K

Main Segment (Y)

Reportable segment

Lyell Immunopharma Revenue by Period

Lyell Immunopharma Revenue by Year

DateRevenueChange
2025-12-31$36.00K-40.98%
2024-12-31$61.00K-53.08%
2023-12-31$130.00K-99.85%
2022-12-31$84.68M695.15%
2021-12-31$10.65M37.31%
2020-12-31$7.76M1080.52%
2019-12-31$657.00K-

Lyell Immunopharma generated $36.00K in revenue during NA 2025, up -40.98% compared to the previous quarter, and up 0.46% compared to the same period a year ago.

Lyell Immunopharma Revenue by Quarter

DateRevenueChange
2026-06-30$4.00K100.00%
2026-03-31$2.00K-66.67%
2025-12-31$6.00K-60.00%
2025-09-30$15.00K87.50%
2025-06-30$8.00K14.29%
2025-03-31$7.00K-36.36%
2024-12-31$11.00K-67.65%
2024-09-30$34.00K161.54%
2024-06-30$13.00K333.33%
2024-03-31$3.00K-76.92%
2023-12-31$13.00K-48.00%
2023-09-30$25.00K-7.41%
2023-06-30$27.00K-58.46%
2023-03-31$65.00K-99.87%
2022-12-31$48.39M1612766.67%
2022-09-30$3.00K-99.99%
2022-06-30$35.74M6363.11%
2022-03-31$553.00K-80.40%
2021-12-31$2.82M2.43%
2021-09-30$2.75M4.83%
2021-06-30$2.63M7.48%
2021-03-31$2.44M5.75%
2020-12-31$2.31M116.07%
2020-09-30$1.07M-65.68%
2020-06-30$3.12M148.25%
2020-03-31$1.26M-

Lyell Immunopharma generated $4.00K in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up 57.14% compared to the same period a year ago.

Lyell Immunopharma Revenue Breakdown

Lyell Immunopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Reportable segment$36.00K$61.00K

Lyell Immunopharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 26Mar 26Dec 25Sep 25Jun 25Mar 25
Reportable segment$4.00K$2.00K$6.00K$15.00K$8.00K$7.00K

Lyell Immunopharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Reportable segment (100.00%).

Lyell Immunopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMRNAmarin$182.75M$39.08M
ACIUAC Immune$14.80M-
SLNSilence Therapeutics$559.00K-
LYELLyell Immunopharma$36.00K$4.00K
GNLXGenelux$8.00K-
EDITEditas Medicine--
ALDXAldeyra The--
CABACabaletta Bio--
ALLOAllogene Therapeutics--
KYTXKyverna Therapeutics--
LRMRLarimar Therapeutics--

LYEL Revenue FAQ

What is Lyell Immunopharma’s yearly revenue?

Lyell Immunopharma's yearly revenue for 2025 was $36K, representing a decrease of -40.98% compared to 2024. The company's yearly revenue for 2024 was $61K, representing a decrease of -53.08% compared to 2023. LYEL's yearly revenue for 2023 was $130K, representing a decrease of -99.85% compared to 2022.

What is Lyell Immunopharma’s quarterly revenue?

Lyell Immunopharma's quarterly revenue for Q2 2026 was $4K, a 100.00% increase from the previous quarter (Q1 2026), and a -50.00% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $2K, a -66.67% decrease from the previous quarter (Q4 2025), and a -71.43% decrease year-over-year (Q1 2025). LYEL's quarterly revenue for Q4 2025 was $6K, a -60.00% decrease from the previous quarter (Q3 2025), and a -45.45% decrease year-over-year (Q4 2024).

What is Lyell Immunopharma’s revenue growth rate?

Lyell Immunopharma's revenue growth rate for the last 3 years (2023-2025) was -72.31%, and for the last 5 years (2021-2025) was -99.66%.

What are Lyell Immunopharma’s revenue streams?

Lyell Immunopharma's revenue streams in c 25 are Reportable segment

What is Lyell Immunopharma’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Lyell Immunopharma was Reportable segment. This segment made a revenue of $36K, representing 100.00% of the company's total revenue.